Drug Interactions between Brukinsa and olutasidenib
This report displays the potential drug interactions for the following 2 drugs:
- Brukinsa (zanubrutinib)
- olutasidenib
Interactions between your drugs
zanubrutinib olutasidenib
Applies to: Brukinsa (zanubrutinib) and olutasidenib
Consumer information for this interaction is not currently available.
MONITOR: Coadministration with inducers of CYP450 3A4 may decrease the plasma concentrations of zanubrutinib, which is primarily metabolized by the isoenzyme. When zanubrutinib was administered in clinical study subjects with multiple doses of rifampin, a potent CYP450 3A4 inducer, zanubrutinib peak plasma concentration (Cmax) and systemic exposure (AUC) decreased by 92% and 93%, respectively. When coadministered with multiple doses of rifabutin, a moderate CYP450 3A4 inducer, zanubrutinib Cmax and AUC decreased by 48% and 44%, respectively, in healthy subjects. Based on pharmacokinetic modeling, coadministration with multiple doses of efavirenz, another moderate CYP450 3A4 inducer, is predicted to decrease zanubrutinib Cmax and AUC by 58% and 60%, respectively. Reduced efficacy of zanubrutinib may occur. The interaction has not been studied with other, less potent inducers.
MANAGEMENT: The potential for diminished pharmacologic effects of zanubrutinib should be considered during coadministration with CYP450 3A4 inducers. Alternative treatments may be required if an interaction is suspected.
Drug and food interactions
zanubrutinib food
Applies to: Brukinsa (zanubrutinib)
Grapefruit juice and Seville orange juice can increase the blood levels of zanubrutinib. This may increase side effects such as rash, diarrhea, constipation, cough, hemorrhage, development of other cancers, abnormal heart rhythm, and impaired bone marrow function resulting in low numbers of different types of blood cells. You may also be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. You should avoid the consumption of Seville oranges, Seville orange juice, grapefruit and grapefruit juice during treatment with zanubrutinib. Be sure to take the medication at approximately the same time(s) everyday to maintain consistent blood levels and effects. Talk to your doctor or pharmacist if you have questions on how to take this or other medications you are prescribed. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
olutasidenib food
Applies to: olutasidenib
Olutasidenib should be taken at about the same time each day, on an empty stomach at least 1 hour before or 2 hours after a meal. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.